For the first time, we have demonstrated that expression of this membrane-associated MMP inhibitor is regulated by TGF-β1 in a breast cancer cell culture model, suggesting that RECK could be involved in the molecular mechanisms of breast cancer progression. Here, TGFB1 is linked to breast carcinoma.